| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Jun 17, 2025 | PUMA BIOTECHNOLOGY, INC. | Director | Sell | 28.8 | -11,610 | -13.34% | ✓ | $39.5K |
| Jun 13, 2024 | Jun 17, 2024 | PUMA BIOTECHNOLOGY, INC. | Director | Sell | 18.8 | -11,000 | -25.00% | ✓ | $37.1K |
| Jun 13, 2023 | Jun 15, 2023 | PUMA BIOTECHNOLOGY, INC. | Director | Sell | 91.3 | +17,000 | 62.96% | ✓ | $34.5K |
| Feb 11, 2021 | Feb 16, 2021 | Voyager Therapeutics, Inc. | CFO | Sell | 36.3 | -3,186 | -6.49% | ✓ | $24.1K |
| Jan 12, 2021 | Jan 14, 2021 | Voyager Therapeutics, Inc. | CFO | Sell | 36.3 | -2,942 | -5.66% | ✓ | $25.4K |
| Jan 21, 2020 | Jan 29, 2020 | Voyager Therapeutics, Inc. | CFO | Sell | 28.8 | -3,128 | -11.31% | ✓ | $41.8K |
| Apr 1, 2015 | Apr 3, 2015 | INSULET CORP | CFO | Sell | 46.3 | -814 | -2.13% | ✗ | $25.9K |
| Mar 2, 2015 | Mar 4, 2015 | INSULET CORP | CFO | Sell | 91.3 | +9,402 | 32.62% | ✗ | $26.7K |
| Mar 1, 2015 | Mar 3, 2015 | INSULET CORP | CFO | Sell | 46.3 | -1,091 | -3.65% | ✗ | $34.6K |